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Background: Co-infection with S. mansoni and Human Immunodeficiency Virus-1 (HIV-1) has been described in
sub-Saharan Africa. However, few community-based studies have been conducted to assess the association
between the two diseases. The present study examined whether the infection with HIV-1 is associated with an
altered susceptibility to S. mansoni infection by comparing the prevalence and intensity of S. mansoni infection
among those infected and not infected with HIV-1. Any influence of HIV-1 associated immunodeficiency on the
intensity of S. mansoni infection was also investigated.
Methods: A cross-sectional study was conducted among 1,785 randomly selected adults (aged 21–55 years) in
fishing villages of north-western Tanzania. Single stool samples were obtained and examined for S. mansoni eggs
using the Kato Katz technique. Finger prick and venous blood samples were collected for HIV-1 screening and
CD4+ cell quantification. Demographic information was collected by questionnaire.
Results: Of the 1,785 individuals from whom complete data were obtained, 854 (47.85%, 95% CI; 40.46 – 56.57)
were infected with S. mansoni and had a mean intensity of 183.21(95% CI; 165.61-202.70) eggs per gram of faeces
(epg). A total of 125 individuals (6.29%, 95% CI 3.59-11.04) were infected with HIV-1 and only 40% (n=50) of them
were co-infected with S. mansoni. No differences in prevalence of S. mansoni infection or intensities of infection,
as estimated by egg count (epg), were observed between HIV-1 sero-positive individuals and HIV-1 negative
individuals. In generalized regression models (adjusted for sex, age, occupation, residence and level of education),
being infected with HIV-1 did not increase the risk (APR=1.01, 95%; 0.83-1.21, P=0.93) or intensity (AOR = 0.84,
95% CI; 0.56-1.25, P = 0.33) of S. mansoni infection. Among individuals co-infected with HIV-1 and S. mansoni infection,
the intensity of infection (epg) was not associated (P = 0.21) or correlated (P = 0.13) with CD4+ cell counts.
Conclusion: Our findings suggest that HIV-1 infection may not have a major effect on S. mansoni infection or on the
excretion of eggs from the co-infected individuals. However, further studies are needed to understand the biological
interaction between HIV-1 and S. mansoni in a large cohort of co-infected individuals.
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In the past two decades, epidemiological studies have
reported an overlap of Human Immunodeficiency (HIV-1)
and S. mansoni infections in sub-Saharan Africa [1-3],
leading to co-infection in highly endemic regions [1-4].
Schistosoma mansoni is focally distributed in the region,
its distribution being largely influenced by the distribution
of its intermediate snail host and human–water contact
behaviours [5,6]. In addition, the development of its
related morbidities is influenced by genetic factors of
the affected population [7], immune responses against the
parasites or eggs [8] and changes in body physiology with
increased age [9]. These factors may influence the pre-
valence and intensity of infection patterns in endemic
populations. In contrast, HIV-1 is widely distributed and
its transmission involves a combination of multiple factors
including demographic factors and socio-economic status,
epidemiological settings (rural versus urban) and sexual
behaviours [10-12].
In areas where S. mansoni is highly endemic, such as
in fishing villages along the Lake Victoria shores in east
Africa [13], the migratory behaviour of fishermen and
women [14], multiple sexual partner networks [11],
living in clusters and isolated localities away from basic
health services, a high prevalence of sexual transmitted
diseases [15] and social cultural behaviours [11,12,15]
increase the risk of HIV-1 transmission. The overlap of
multiple risk factors associated with the two diseases in
the same geographical setting or the biological interaction
between HIV-1 and S. mansoni [2,10-12,14] have been
proposed to increase the risk of individuals to be co-
infected with both HIV-1 and S. mansoni [2,11,13,15].
In co-infected individuals, immunological studies have
described a number of biological mechanisms through
which chronic HIV-1 infection could affect S. mansoni re-
lated morbidities [16]. These mechanisms could result in
differences in the prevalence and intensity of S. mansoni
infection [17,18]; the efficiency of parasite egg excretion
[4,17,18]; morbidity patterns [19] and the response to
anthelmintic treatment among HIV-1 infected and non in-
fected people [20,21]. However, despite the possible inter-
action between the two diseases, few community based
studies have been conducted to explore the possible inter-
action between HIV-1 and S.mansoni infections [4,17,18].
The current study examined whether infection with
HIV-1 is associated with an altered susceptibility to
S. mansoni infection by comparing the prevalence and
intensity of S. mansoni infection among those infected
and not infected with HIV-1. As HIV-1 infection is
associated with reduced CD4+ cell counts, and as the
human immunological status is known to influence
schistosome-human reactions, we also tested if there
was an association or correlation between the intensity
of S.mansoni infection and the immunological status, asmeasured by CD4+ cell counts, in people co-infected
with HIV-1 and S. mansoni.
Methods
Study population and study area
The study was conducted at Ilemela district, Mwanza re-
gion, located at 32-34°E and 2 - 4°S, on the southern
shores of the Lake Victoria, north-western Tanzania.
The area experiences a temperature range from 18°C to
28°C and the mean annual rainfall of 1068 mm. Four
villages Sangabuye, Kayenze, Igalagala and Igombe, were
chosen for the present study due to their close proximity
to the lake. The majority of the population are of Sukuma
tribe. Other migrant tribes are Kerewe, Jita, and Kara. The
majority of the villagers in the four villages depend on the
lake for domestic and economic activities such as washing,
bathing, cooking, drinking and recreation. The main eco-
nomic activities in the four villages are fishing and far-
ming. For high water contact levels, the residents have a
high risk of being infected with S. mansoni [22,23] and
high occupational exposure maintains high intensities of
S. mansoni infection into adulthood [24]. Annual mass
drug administration (MDA) using praziquantel and alben-
dazole against helminth infections in these villages is
organised within the school environment and focuses on
school-going children, not the adult population.
The high rate of sexual mixing within the fishing
villages increases the risk of HIV-1 transmission in the
adult population [11]. In 2003, the prevalence of HIV-1
infection in individuals aged 15–60 years living in
Kayenze and Sangabuye villages was estimated to be
10% [22] and the National HIV-1 seroprevalence results
of 2012 have indicated that the prevalence of HIV-1 is
6% in the age group 15–60 years [25].
Study design, inclusion and exclusion criteria
This cross-sectional study was conducted between
September 2012 and December 2012. All people who
had lived in the study villages for more than two years,
and were aged 21 to 55 years, were eligible for enrolment.
Individuals with a history of treatment for schistosomiasis
(praziquantel) in the past six months and those who were
on anti-retroviral treatment were excluded from the study.
To determine an adequate sample size, we assumed
that among people not infected with HIV-1, 50% were
infected with S. mansoni. In order to determine a dif-
ference of 20% among people with HIV-1 who were
infected with S. mansoni, at a power of 80% and 95%
confidence interval, we required at least 103 people in-
fected with HIV-1. This sample size was calculated using
Stata 12 using the command sampsi 0.5 0.7, power (.80).
To achieve this number of HIV infected we needed to
screen 1,760 people assuming an HIV-1 prevalence of
6% [25] and refusal rate of 10%.
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households and household members to participate in the
study. At first, random sampling was used to select
1,785 households from a list of 4586 households. Then,
from every selected household, random sampling was
used to select one individual from all eligible persons in
the household. If the selected individual was not present
on the day of screening, the house was revisited three
times on different days and if the selected subject de-
clined to participate or was not available after multiple
attempts, a new member of the household was chosen.
Similarly, if the selected household remained vacant after
multiple visits, the household was substituted by a
neighbouring one.
Data collection
(i) Human Immunodeficiency Virus screening and
CD4+ analysis
Human Immunodeficiency Virus-1 testing was con-
ducted according to the Tanzanian National HIV algo-
rithms which recommend the use of a rapid test qualitative
immunoassay [26]. Study participants were counselled
before and after HIV testing as per requirement of the
country algorithms. The study used Determine® (Alere
Determine, Chiba, Japan) followed by UNI-GOLD® (Trinity
Biotech PLC, Bray, Ireland) for the participants who had a
positive result with Determine [26]. The test was con-
ducted according to the standards provided by the manu-
facturers. For individuals who had a Determine positive
test but a negative UNIGOLD test, a dry blood spot
was obtained for Enzyme Immunosobent Assay (ELISA)
testing. Within 24-hours of blood sample collection, the
quantification of CD4+ cells was carried out using a FACS-
Calibur machine (Becton Dickinson-BD Biosciences, San
Jose, CA, USA) following standard procedures [27].
(ii)Parasitological screening for Schistosoma mansoni
A single stool sample was collected from all study par-
ticipants. Four Kato Katz thick smears were prepared from
different parts of the single stool sample using a template
of 41.7 mg (Vestergaard Frandsen, Lausanne, Switzerland),
following a standard protocol [28-30]. After 24 hours, the
smears were independently examined for S. mansoni eggs
by two experienced laboratory technicians of the National
Institute for Medical Research (NIMR) laboratory. For
quality assurance, a random sample of 10% of the negative
and positive Kato Katz thick smears were re-examined by
a third technician.
In addition to stool and blood examination, demo-
graphic information on sex, age, occupation, marital sta-
tus, village of residence, number of years lived in currentresidence and level of education were collected by
questionnaire.
Ethical considerations
Ethical approval was obtained from the Higher Degrees Re-
search and Ethics Committee of the School of Public
Health, Makerere University (Institutional Review Board
(IRB) -00005856/2011) and from the Bugando University
College of Health Sciences and Allied Sciences-Institutional
Review Board, (BREC/001/32/2011). Ethical clearance was
granted by the National Ethical Review Committee,
National Institute for Medical Research, Tanzania and the
study was registered in the clinical trial network, Clinical
Trial (Number:- NCT-01541631). The study received fur-
ther clearance from the regional and district adminis-
trative authorities of Mwanza region and Ilemela district.
Swahili translated informed assent and consent forms
were used to obtain children and adult participants’ con-
sent respectively. For illiterate individuals, a thumb print
was used to sign the assent and consent forms after a
clear description of the study objective and acceptance to
participate.
All study participants who were infected with S. mansoni
were treated with praziquantel (40 mg/kg) according to
World Health Organization (WHO) guidelines, irrespec-
tive of their HIV-1 sero-status. All HIV-1 infected indi-
viduals found to have CD4+ < 350 cells/μL were referred
to the Care and Treatment Clinic (CTC) for assessment of
their eligibility for antiretroviral therapy (ART).
Statistical analysis
The data were double entered using CSPro and the final
data set was stored in a MySQL database. Data analysis
was performed using Stata version 12 (Stata Corp, College
station, Texas, USA). The prevalence of S. mansoni 95%
confidence interval (95% CI) were obtained by binomial
logistic regression taking into account clustering by vil-
lages. Comparisons of prevalence by demographic factors
for S. mansoni infection were tested for significance using
the chi-square test (χ2) or the Fisher exact test for cate-
gorical variables before running regression models. The
arithmetic mean of S. mansoni egg counts for each parti-
cipant was calculated from the counts of four Kato Katz
thick smears and multiplied by 24 to obtain individual
eggs per gram of faeces. S. mansoni egg counts were over
dispersed so were logarithmically transformed and used to
calculate the geometric mean egg per gram of feaces
(GM-epg) that was obtained as the antilog of the mean of
the transformed egg counts. Geometric mean egg counts
for S. mansoni between various demographic factors were
compared using t-test or ANOVA. Intensity of infection
was categorized according to WHO criteria as : 1–99 epg,
100–399 epg, ≥400 epg defined as low, moderate and
heavy intensities of infection respectively [29,30]. To test
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and degree of immunosupression with HIV-1 as measured
by CD4+ cell counts, linear regression analyses were done
to calculate Pearson correlation coefficient for individuals
co-infected with S. mansoni and HIV-1 adjusting for sex
and age.
We also assessed whether using cut-offs of 350 and 200
CD4+ cells/μL, which are used for treatment referral and
as a definition of Acquired Immunodeficiency Syndromes
(AIDS) [31] respectively, influence susceptibility with
S.mansoni. To control for the confounding effects of age,
sex, occupation, marital status, level of education, village
of residences and duration of residence on the association
between HIV-1 and S. mansoni infections binomial logis-
tic and generalized regressions models were done for all
people whether infected with S. mansoni or not. Stepwise
backward procedures were used to determine whether
these variables were independent factors of S. mansoni
infection by use of adjusted prevalence ratio (APR) for
logistic regression. To control for confounding regarding
intensity of infection, linear regression models were run
for people who were infected with S .mansoni. Stepwise
backward procedures were used to determine whether
these variables were independent factors of intensity of
S. mansoni infection by using adjusted odds ratios (AOR)
for linear models and the 95% confidence interval (CI).
Results
(i) Demographic characteristics of study participants
round decimals to one point
A total of 1,785 individuals who participated in this
study, 52.9% (945/1785) were female and 47.0% (n = 840)
were male. The mean age of the study participants was
35.6 ± 9.74 years (with no significant difference in mean
age between males and females, P = 0.4). The majority of
the study participants had received a primary school
education n = 1078, (60.39%), n = 76 (4.3%) had attained
secondary/college education, n = 631, (35.4%) were
illiterate. The majority were married (n = 1,257 (70.9%),
234 (13.1%) reported being in a long-term, stable relation-
ship and 291 (16.4%) were either separated or divorced/
widowed. There were 1,256 (70.36%) farmers, 255 (14.3%)
fishermen and 223 (15.4%) small-scale business men and
women. Overall, 97% of the study participants performed
their economic activities within their villages.
(ii)Prevalence of Schistosoma mansoni infection and
association with HIV-1
The overall prevalence of S. mansoni was 854/1,785
(47.84%, 95%CI, 40.46-56.57), which was higher among
males than females (472/840, 56.19% versus 382/941,40.59%, P < 0.0001) (Table 1). There was a relationship bet-
ween age and S. mansoni infection, the older age had lower
prevalence compared to young age groups (P < 0.00001).
Fishing-related occupations were associated with a higher
prevalence of infection compared to other economic
activities (P < 0.0001). Similarly, the prevalence varied
significantly by villages of residence (P < 0.0001), with in-
habitants of Kayenze and Igalagala having the highest
prevalence. However, S. mansoni infection did not vary by
duration of residence (Table 1). In relation to HIV-1 seros-
tatus, 50/125 (7.00%) were co-infected with HIV-1 and
S. mansoni infection. HIV-1 seronegative individuals had a
higher prevalence of S. mansoni infection compared to the
HIV-1 seropositive individuals but this difference was not
statistically significant (P = 0.06) (Table 1). In generalised
regression models (Table 1) adjusted for sex, age, marital
status, education levels, occupation, village of residence,
and duration of stay, HIV-1 was not an independent
risk factor for infection with S. mansoni (APR =
1.01,95% CI; 0.84 - 1.21, P = 0.93). The main independent
risk factors of S. mansoni infection were being of the
male gender (APR = 1.27, 95% CI;1.14-1.42, P < 0.001), in-
volvement in fishing activities (APR = 1.28,95% CI;1.07–
1.53, P < 0.01), living in Igalagala (APR = 1.31,95%
CI;1.12-1.52, P < 0.001) and Kayenze (APR = 1.32,95%
CI;1.15-1.51, P < 0.001) villages.
(iii)Intensity of S.mansoni infection and its association
with HIV-1
The overall geometrical mean egg per gram of faeces
(GM-epg) for study participants with detectable S. man-
soni eggs was 182.85epg (95% CI: 165.27 – 202.31).
Males had higher intensities of infection (238.31epg,
95% CI: 206.63 – 274.84) than females (132.07epg, 95%
CI: 115.29 – 151.28, P < 0.0001) (Table 2). The youngest
age group (21–30 years) had the highest intensities of
infection than older age groups (Table 2). Also, those in-
volved in fishing activities had the highest intensities of in-
fection compared to other economic activities (P < 0.0012).
In addition, illiterate individuals had the highest intensity
of infection compared to literate individuals (P < 0.034). In-
habitants living in Kayenze and Igalagala villages had the
highest intensities of infection compared to those who
were living in the other two villages (P < 0.002) (Table 2).
Of the 854 individuals with detectable S. mansoni eggs,
352/854 (41.21%), 232/854 (27.16%) and 270/854 (31.61%)
had light, moderate and heavy infections respectively, as
defined by WHO [29,30].
HIV-1 seronegative individuals had higher intensities of
infection (186.98epg, 95% CI; 168.39-207.61) than HIV-1
seropositive individuals (126.78epg, 95% CI; 86.59 –
185.61) but the observed difference did not reach signifi-
cance (P = 0.38). In a multiple linear regression model
Table 1 Prevalence and risk factors of Schistosoma mansoni among residence of fishing villages of north-western
Tanzania
Variable No. infected Prevalence of S. mansoni (95% CI) Crude prevalence ratio (95% CI) Adjusted prevalence ratio (95% CI)
Overall 854 47.84 (40.41 – 56.60) ----- -----
Sex
Female 382 40.29 (32.43 – 50.00) 1 1
Male 472 56.14 (49.19 – 64.06)* 1.39 (1.26 – 1.54)** 1.27 (1.14 – 1.42)***
Age (in years)
21 – 30 365 53.18 (47.48 – 59.55)* 1.22 (1.99 – 1.48) 1.19 (0.98 – 1.45)
31 – 40 292 47.66 (38.38 – 59.19) 1.09 (0.99 – 1.19) 1.12 (0.92 – 1.37)
41 – 50 125 38.96 (29.80 – 50.93) 0.89 (0.76 – 1.04) 0.91 (0.72 – 1.13)
51 – 55 72 43.71 (35.49 – 53.83) 1 1
Marital status
Married 591 47.20 (36.04 – 61.83) 1 1
Single 263 48.63 (29.60 – 79.87) 1.03 (0.82 – 1.29) 1.05 (0.95 – 1.16)
Education level
Literate 564 49.04 (43.27 – 55.59) 1 1
Illiterate 290 45.44 (34.83 – 59.28) 0.93 (0.91 – 0.94) 0.98 (0.88 – 1.08)
Occupation
SME 129 44.14 (36.14 – 53.91) 1 1
Peasants 561 45.11 (37.98 – 53.58 1.02 (0.89 – 1.16) 1.06 (0.86 – 1.24)
Fishing 164 66.28 (55.77 – 78.78)* 1.52 (1.42 – 1.59)** 1.27 (1.06 – 1.53)***
Village of residences
Igombe 176 40.42 (29.82 – 54.78) 1 1
Igalagala 141 55.47 (39.08 – 78.72)* 1.37 (1.31 – 1.44)** 1.31 (1.12 – 1.52)***
Kayenze 351 54.21 (42.96 – 68.38)* 1.34 (1.25 – 1.44)** 1.32 (1.15 – 1.51)***
Sangabuye 186 41.24 (26.34 – 64.58) 1.02 (0.88 – 1.78) 1.06 (0.89 – 1.25)
Duration of residences (in years)
3 – 5 152 50.16 (43.42 – 57.94) 1 1
6 – 10 169 50.21 (38.90 – 64.79) 1.01 (0.80 – 1.25) 1.01 (0.86 – 1.18)
11 – 20 187 49.76 (38.92 – 63.61) 0.98 (0.85 – 1.16) 1.01 (0.88 – 1.16)
≥21 346 48.69 (43.06 – 55.06) 0.97 (0.92 – 0.99) 0.96 (0.85 – 1.09)
CD4+ cell counts/μL
<350 28 38.36 (28.63 – 51.38) 1 -----
≥350 22 44.89 (28.96 – 69.61) 1.17 (0.91 – 1.51) -----
HIV-1 sero-status
Negative 804 48.12 (41.04 – 56.43) 1 1
Positive 50 39.52 (27.64 – 56.49) 0.92 (0.78 – 1.09) 1.01 (0.84 – 1.21)
*P < 0.001 from χ2; **P < 0.001 and ***P < 0.001 from binomial family model.
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tion level, residence and duration of stay, the intensity
of S. mansoni infection was not associated with HIV-1
infection (AOR = 0.84,95% CI; 0.56 – 1.25) (Table 2).
The intensity of infection was associated with being of
male gender (AOR = 1.65,95% CI; 1.32-2.08, P < 0.0001),
young ages (21–30 years; AOR = 1.68,95% CI; 1.14-2.48,
P < 0.01), involvement in fishing activities (AOR = 1.62,95%CI; 1.10-2.41, P < 0.01), being illiterate (AOR = 1.33,95% CI;
1.07 – 1.66, P < 0.014) and living in the study villages.
(iv)Association between immune status and S.
mansoni infection
Of the 125 individuals infected with HIV-1, 50/125,
(40.00%, 95% CI; 31.58 - 48.42) had detectable S. mansoni
Table 2 Factors associated with infection intensity among people infected with S.mansoni residing in fishing villages
of north-western Tanzania
Variable No. infected GM-epg (95% CI) F-ratio (P-level) COR (95% CI) AOR (95% CI)
Overall 854 183.21 (165.61 – 202.70) ------ ------- -------
Sex
Female 382 132.02 (115.33 – 151.14) − 4.7386* (P < 0.0001) 1 1
Male 472 238.86 (207.14 – 275.44) 1.61 (1.48 – 2.21) 1.65 (1.32 – 2.08)
Age (in years)
21 – 30 368 220.20 (188.16 – 257.71) 2.03** (P = 0.11) 1.61 (0.65 – 1.54) 1.68 (1.14 – 2.48)
31 – 40 286 177.55 (149.10 – 211.41) 1.30 (0.89 – 1.91) 1.32 (0.89 – 1.97)
41 – 50 127 136.85 (109.18 – 171.54) 1.004 (0.65 – 1.91) 1.08 (0.69 – 1.67)
51 – 55 73 136.85 (109.18 – 171.54) 1 1
Marital status
Married 591 173.06 (153.51 – 195.09) − 0.8094* (P = 0.42) 1 1
Single* 263 204.46 (168.53 – 248.04) 1.02 (0.93 – 1.04 0.99 (0.94 – 1.05)
Occupation
SSB 129 141.93 (108.59 – 185.21) 6.75** P < 0.0012 1 1
Peasants 561 161.72 (142.87 – 183.06) 1.14 (0.82 – 1.57) 1.12 (0.81 – 1.54)
Fishing 164 308.84 (246.20 – 387.41 2.18 1.50 – 3.15) 1.62 (1.10 – 2.41)
Education level
Literate 564 173.54 (153.35 – 196.38) −2.1185* (P < 0.0344) 1 1
Illiterate 290 197.38 (164.80 – 236.40) 1.14 (0.91 – 1.41) 1.33 (1.07 – 1.66)
Village of residence
Igombe 176 144.14 (116.73 – 178.00) 3.26** (P < 0.0211) 1 1
Igalagala 141 224.83 (175.65 – 287.77) 1.56 (1.12 – 2.17) 1.71 (1.23 – 2.40)
Kayenze 351 202.39 (173.12 – 236.61) 1.40 (1.07 – 1.84) 1.62 (1.23 – 2.13)
Sangabuye 186 163.07 (129.35 – 205.58) 1.13 (0.83 – 1.54) 1.38 (1.001 – 1.89)
Duration of residence (in years)
3 − 5 152 230.94 (180.85 – 294.91) 1.89** (P = 0.13) 1 1
6 – 10 169 160.53 (122.74 – 209.95) 0.69 0.48 – 1.01 0.71 (0.50 – 1.01)
11 – 20 187 188.01 (154.38 – 228.95) 0.81 (0.59 – 1.11) 0.86 (0.64 – 1.17)
≥21 346 165.24 (141.06 – 193.58) 0.71 (0.54 – 0.95) 0.73 (0.55 – 1.04)
CD4+ cell counts/μL
<350 28 154.27 (85.16 – 279.48) 1.5410* (P = 0.13) 1
≥350 22 93.26 (60.42 – 143.95) 1.09 (0.54 – 2.08) ------
HIV-1 serostatus
Negative 804 186.83 (168.15 – 207.59) 0.882* (P = 0.38) 1 1
Positive 50 126.78 (86.59 – 185.61) 0.76 (0.51 – 1.13) 0.84 (0.56 – 1.25)
● Determined by based on t-tests **Determined by Anova.
● COR = Crude Odd Ratio.
● AOR = Adjusted Odd Ratio.
● Single* - male of female individuals living alone/not married.
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infection for the entire cohort was 50/1,785 (2.80%). Of
the co-infected individuals, the proportions of lightly,
moderately and heavily co-infected individuals were 25/50,
(50.00%, 14/50 (28.00%) and 11/50 (22.00%) as defined by
WHO [29,30]. The prevalence of S. mansoni in HIV-1infected individuals with CD4+ counts <350 cells/μL was
28/75 (37.33%) compared to 22/50 (44.00%) in those who
had CD4+ counts ≥350 cells/μL (P = 0.47). Co-infected
individuals with CD4+ counts <350 cells/μl had a higher
GM-epg of S. mansoni infection (154.27epg, 95% CI;
85.16-279.48) compared to those who had CD4+
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143.95), but the difference was not significant (P = 0.13).
Among those with CD4+ counts <200 cells/μL, 24.44%
(n = 11) were co-infected with HIV-1 and S. mansoni,
while among those with CD4+ cell counts ≥ 200 cells/μL,
50.65% (n = 39) were co-infected. Considering the inten-
sities of S. mansoni infection, those who had CD4+ counts
of <200 cells/μL had higher GM-epg of S. mansoni infec-
tion (184.83epg, 95% CI: 54.85-622.82), compared to those
who had CD4+ counts of ≥200 cells/μL (110.376epg, 95%
CI; 75.63 – 161.07), but the difference between the two
groups did not reach significance (P = 0.13).
For individuals who were mono-infected with HIV-1, 45/
75 (60.00%) had CD4+ counts <350 cells/μL and 30/75
(40.00%) had CD4+ counts ≥ 350 cells/μL. The median
CD4+ counts for individuals who were infected with HIV-1
only was 231.5(range: 132–512.5) cells/μL and those who
were co-infected with S. mansoni and HIV-1 was 308.5
(range: 202–586) cells/μL (P = 0.14).
For individuals who were co-infected, the intensity of in-
fection was not associated with CD4+ count at both univa-
riate (P = 0.11) and multivariate level (P = 0.21) (correcting
for age, sex, village of occupation, residence, education
level) (R2 = 0.3027, adjusted R2 = 0.1458, F = 0.075). No
correlation was observed between intensity of S. mansoni
infection (epg) and CD4+ cell counts among the co-
infected individuals (r = −0.37, P = 0.13) (Figure 1).
Discussion
The present study villages of North-western Tanzania are
endemic to S. mansoni and HIV-1 infections. Co-infection
with HIV-1 and S. mansoni in a single human host does
also occur in the study population. In the present study
area, no differences in prevalence of S. mansoni infection
or egg counts were observed between HIV-1 sero-positive
participants and HIV-1 sero-negative individuals. AfterFigure 1 Scatter plot of correlation of S. mansoni egg counts
and CD4+ counts in individuals co-infected with HIV-1 and
S. mansoni. No correlation was observed between egg excretions
and CD4+ counts levels (r = −0.37, P = 0.13).adjusting for other factors in the statistical models, no as-
sociation was observed between the HIV-1 serostatus and
the prevalence as well as the intensity of S.mansoni infec-
tion. Furthermore, no correlation was observed between
CD4+ cell counts and S. mansoni egg counts.
Our observations were consistent with the study of
Kallestrup et al. [18], in rural Zimbabwe; although that
study was limited by low intensities of S. mansoni in-
fection, no difference in egg counts or prevalence was
observed between HIV-1 seropositive or HIV-1 sero-
negative participants infected with S. mansoni [18].
These observations are inconsistent with reports from
previous similar studies in Ethiopia and Western Kenya
[4,17], where individuals co-infected with HIV-1 and S.
mansoni infections excreted fewer egg counts per gram
of faeces than HIV-1 negative individuals infected with
S. mansoni despite the two groups having similar worm
burdens [4], as determined by Circulating Cathodic
Antigen (CCA) levels (a S. mansoni gut antigen which is
regurgitated by juvenile and adult stages as a by-product
of host red blood cell digestion) [32]. Complementary to
these observations in human hosts, a lower egg output
in immunodeficient murine models has also been des-
cribed [33-38]. In these models, the maturation of the
worm is delayed; the fecundity of the female worm af-
fected and transposition of the eggs to the lumen of the
intestine is reduced. These combine to significantly
lower the level of S.mansoni egg output compared with
immunocompetent mice, despite having a comparable
number of adult worms [33-35,37,38].
In the present study cohort, co-infected individuals
with lower CD4+ cell counts levels categorised either
at <200 cells/μL or <350 cells/μL had higher GM-epg of
S. mansoni infection compared to those who had higher
CD4+ cell count levels. However the difference was not
statistically significant. Previous similar studies have re-
ported lower S. mansoni egg counts in individuals with
lower CD4+ cell counts [4,18]. It is important to note
that, HIV-1 seropositive individuals included in the
present study had higher median CD4+ cell counts as
compared to similar cohort included in other similar
study in rural Zimbabwe, which had very low CD4+ cell
counts [18]. It is possible that the previous studies,
which observed lower S. mansoni egg counts in HIV-1
seropositive individuals with lower CD4+ cell counts, were
focused on cohorts suffering more advanced stages of
HIV-1 associated disease [4,18]. It is worthwhile noting
that decreased CD4+ cell counts have also been reported
in HIV-1 seronegative individuals infected with S. man-
soni, indicating an association between CD4+ lymphocyto-
penia and S. mansoni infection [18,39].
In the present study, no direct association or cor-
relation was observed between the geometrical mean
S. mansoni epg and CD4+ cell counts among individuals
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were consistent to a similar study in rural Zimbabwe [18].
The results of the present study and those of other authors
[18] indicate that even HIV-1 co-infected individuals,
regardless of the immune status as measured by CD4+
count levels, could have egg counts close to HIV-1 negative
individuals infected with S. mansoni [18]. In contrast, in co-
infected human hosts in western Kenya, lower CD4+ cell
counts correlated positively with lower egg excretion ratio/
CCA ratio [22,32]. The CD4+ T-helper cells lymphocyte
responses are thought to play a central role in excretion
efficiencies of S. mansoni eggs, with decreasing CD4+ cell
counts correlating with reduced excretion efficiencies of
S. mansoni eggs in murine models [33-38]. It is worth to
note that the degree of induced immunonosuppression
observed in murine models studies, which resulted in lower
S. mansoni egg output and correlated positively with CD4+
cells, was very severe and cannot be compared to mode-
rately CD4+ depleted individuals observed in the present
study. Together, the low numbers of co-infected individuals
observed in the present study, combined with their rela-
tively modest CD4+ depletion, could have reduced the like-
lihood of observing a significant correlation between CD4+
cell count and S. mansoni egg output.
Our study was subject to some limitations. The cross-
sectional nature of the study design may have contri-
buted to the lack of temporal association between HIV-1,
S. mansoni and some of the study variables. Thus, even
though this study was a community-based study with a
large number of study participants, some caution must be
taken with the interpretation of these findings.
Conclusion
In conclusion, no differences in prevalence of S. mansoni
infection or egg count were observed between HIV-1 sero-
positive individuals and HIV-1 sero-negative individuals.
In addition, no association was observed between HIV-1
serostatus and prevalence or intensity of infection with S.
mansoni. Furthermore, no correlation was observed be-
tween CD4+ cell count levels and S. mansoni egg count
levels. Our findings suggest that HIV-1 infection may not
affect S. mansoni disease development and excretion of
eggs from the co-infected individuals. Further research is
needed to test biological interaction using more sensitive
methods of diagnosing S. mansoni, such as quantitative
CCA, and with a much bigger sample size of co-infected
individuals with S. mansoni and HIV-1.
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